I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.9397 USD -2.01% Market Closed
Market Cap: 76m USD
Have any thoughts about
I-Mab?
Write Note

I-Mab
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

I-Mab
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
I-Mab
NASDAQ:IMAB
PP&E Net
ÂĄ82.9m
CAGR 3-Years
27%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
PP&E Net
ÂĄ9.3B
CAGR 3-Years
54%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
PP&E Net
ÂĄ2.9B
CAGR 3-Years
46%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
PP&E Net
ÂĄ1.7B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
9%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
PP&E Net
ÂĄ5.1B
CAGR 3-Years
20%
CAGR 5-Years
25%
CAGR 10-Years
24%
Imeik Technology Development Co Ltd
SZSE:300896
PP&E Net
ÂĄ300.4m
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

I-Mab
Glance View

Market Cap
76m USD
Industry
Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

IMAB Intrinsic Value
0.7454 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

What is I-Mab's PP&E Net?
PP&E Net
82.9m CNY

Based on the financial report for Dec 31, 2023, I-Mab's PP&E Net amounts to 82.9m CNY.

What is I-Mab's PP&E Net growth rate?
PP&E Net CAGR 5Y
25%

Over the last year, the PP&E Net growth was -33%. The average annual PP&E Net growth rates for I-Mab have been 27% over the past three years , 25% over the past five years .

Back to Top